Art

J-GLOBAL ID：202002243830268937   Reference number：20A1014181

Can the prophylactic quadrivalent HPV vaccine be used as a therapeutic agent in women with CIN? A randomized trial

予防的4価HPVワクチンは,CINの女性における治療薬として使用できるか?無作為化試験【JST・京大機械翻訳】

Author (7)： Karimi-Zarchi Mojgan (Endometriosis Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran) ,  Karimi-Zarchi Mojgan (Shahid Sadoughi University of Medical Science, Yazd, Iran) ,  Allahqoli Leila (Endometriosis Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran) ,  Nehmati Ameneh (Islamic Azad University, Yazd, Iran) ,  Kashi Abolfazl Mehdizadeh (Endometriosis Research Center, Iran University of Medical Sciences (IUMS), Tehran, Iran) ,  Taghipour-Zahir Shokouh (Shahid Sadoughi University of Medical Science, Yazd, Iran) ,  Alkatout Ibrahim (Department of Obstetrics and Gynecology, University Hospitals Schleswig-Holstein, Kiel, Germany)
Material： BMC Public Health (Web)
Volume： 20  Issue： 1  Page： 1-7  Publication year： 2020 
JST Material Number： U7448A  ISSN： 1471-2458  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Abstract/Point： Human papillomavirus (HPV) is ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A1014181&from=J-GLOBAL&jstjournalNo=U7448A") }}

Thesaurus term： chi-square test ,  side effect ,  *vaccine ,  Islamic Republic of Iran ,  woman ,  clinical trial ,  prevention ,  cervix tumor ,  risk factor ,  randomized controlled trial
Semi thesaurus term： ヒトパピローマウイルス ,  t検定 ,  悪性度 ,  *パピローマウイルスワクチン ,  ワクチン有効性 , 【Automatic Indexing@JST】

Author keywords (5)： HPV ,  Vaccine ,  Pap smear ,  Cervical cancer ,  Secondary prevention

JST classification (2)： Tumors(=neoplasms)of female genitalia and fetus  (GS04000K) ,  Clinical application of immunotherapeutic agents and blood preparations  (GW22020O)

Reference (48)：

• Nat Rev Cancer; The natural history of cervical HPV infection: unresolved issues; CB Woodman, SI Collins, LS Young; 7; 1; 2007; 11-22; 10.1038/nrc2050; citation_id=CR1
• Lancet; Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis; MH Forouzanfar; 378; 9801; 2011; 1461-1484; 10.1016/S0140-6736(11)61351-2; citation_id=CR2
• Gynecol Oncol; Epidemiology of cervical cancer and human papilloma virus infection among Iranian women - analyses of national data and systematic review of the literature; F Khorasanizadeh; 128; 2; 2013; 277-281; 10.1016/j.ygyno.2012.11.032; citation_id=CR3
• Iran J Basic Med Sci; Human papillomavirus and breast cancer in Iran: a meta-analysis; MR Haghshenas; 19; 3; 2016; 231; citation_id=CR4
• Int J Prev Med; The prevalence of cervical human papillomavirus infection and the most at-risk genotypes among Iranian healthy women: a systematic review and meta-analysis; M Malary; 7; 2016; 70; 10.4103/2008-7802.181756; citation_id=CR5

Terms in the title (5)： 予防 ,  HPVワクチン ,  女性 ,  治療薬 ,  無作為化試験